IRIS
LASAGNA, ANGIOLETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.540
AS - Asia 1.062
EU - Europa 820
SA - Sud America 180
AF - Africa 92
Continente sconosciuto - Info sul continente non disponibili 69
OC - Oceania 3
Totale 3.766
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.492
SG - Singapore 321
CN - Cina 277
IT - Italia 202
HK - Hong Kong 150
VN - Vietnam 140
RU - Federazione Russa 135
BR - Brasile 122
DE - Germania 104
IE - Irlanda 99
FI - Finlandia 72
FR - Francia 62
ZA - Sudafrica 60
IN - India 47
GB - Regno Unito 45
BD - Bangladesh 24
CA - Canada 22
AR - Argentina 18
JP - Giappone 18
TR - Turchia 15
ES - Italia 14
PL - Polonia 13
AT - Austria 11
VE - Venezuela 11
SE - Svezia 10
CO - Colombia 9
IQ - Iraq 9
MA - Marocco 8
NL - Olanda 8
PK - Pakistan 8
EC - Ecuador 7
MX - Messico 7
TN - Tunisia 7
BE - Belgio 6
CZ - Repubblica Ceca 6
PH - Filippine 6
LT - Lituania 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
EG - Egitto 4
HR - Croazia 4
ID - Indonesia 4
JM - Giamaica 4
UA - Ucraina 4
AO - Angola 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KE - Kenya 3
KR - Corea 3
MY - Malesia 3
PE - Perù 3
RO - Romania 3
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
DM - Dominica 2
IL - Israele 2
JO - Giordania 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AS - Samoa Americane 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
MZ - Mozambico 1
NI - Nicaragua 1
PR - Porto Rico 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 3.696
Salva come PNG Salva come JPEG
Città #
San Jose 226
Dallas 181
Singapore 170
Hong Kong 147
Ashburn 145
Chandler 97
Dublin 95
Beijing 88
New York 80
Council Bluffs 73
Ho Chi Minh City 60
Johannesburg 53
Munich 53
Boardman 50
Lauterbourg 45
Los Angeles 45
Helsinki 42
Hanoi 32
Shanghai 32
Milan 30
Turku 30
Santa Clara 24
Moscow 22
Redondo Beach 22
Buffalo 20
Orem 19
Seattle 19
Columbus 18
Rome 18
São Paulo 18
Pescara 16
Pavia 14
Princeton 14
Chennai 13
Frankfurt am Main 13
Lawrence 13
Tokyo 13
Medford 12
Brooklyn 11
Montreal 11
Warsaw 11
Denver 10
San Francisco 10
Stockholm 10
The Dalles 10
Baghdad 8
Düsseldorf 8
Guangzhou 8
Atlanta 7
Cagliari 7
Nuremberg 7
Toronto 7
Vienna 7
Biên Hòa 6
Da Nang 6
Poplar 6
Wilmington 6
Boston 5
Delhi 5
Falkenstein 5
Houston 5
Manchester 5
Porto Alegre 5
Tashkent 5
Washington 5
Amsterdam 4
Ankara 4
Bergamo 4
Buenos Aires 4
Casablanca 4
Dhaka 4
Hangzhou 4
London 4
Mexico City 4
Baku 3
Belo Horizonte 3
Bogotá 3
Brussels 3
Cairo 3
Charlotte 3
Chicago 3
Concord 3
Desio 3
Fortaleza 3
Ha Long 3
Hyderabad 3
Istanbul 3
Lima 3
Luanda 3
Medellín 3
Milwaukee 3
Mumbai 3
Nairobi 3
New Delhi 3
Phoenix 3
Prague 3
Quito 3
Reggio Emilia 3
Rio de Janeiro 3
Tangier 3
Totale 2.372
Salva come PNG Salva come JPEG
Nome #
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 159
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 151
Torque teno virus and cancers: current knowledge 131
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 131
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 120
Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up 116
Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature 113
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 113
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study 107
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study 104
Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? 104
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center 102
The institution of a Multi-disciplinary Italian Breast Unit: Reflections of the first psychosocial research study results on distress and quality of life 99
Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study 96
G-CSF and G-CSF-related vasculitis: A systematic review of the literature and intriguing future research perspectives 94
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 94
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 93
The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study 93
Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA 91
Risk of reactivation of occult hepatitis B during immunotherapy in cancer treatment: myth, reality or new horizons? 84
The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy 83
How to use prophylactic G-CSF in the time of COVID-19 80
Long-COVID in Patients with Cancer Previously Treated with Early Anti-SARS-CoV-2 Therapies in an Out-of-Hospital Setting: A Single-Center Experience 77
Impact of proton pump inhibitors on the onset of gastrointestinal immune‐related adverse events during immunotherapy 77
Vaccine hesitancy in patients with solid tumors: a cross-sectional single-center survey 76
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research 76
The 'hit-and-run' strategy and viral carcinogenesis 74
Infectious complications and immunotherapy: old pitfalls and new horizons 74
Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir 71
Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors 71
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems 71
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 70
Unlocking the Potential: Epstein-Barr Virus (EBV) in Gastric Cancer and Future Treatment Prospects, a Literature Review 69
Vickers micro-hardness of new restorative CAD/CAM dental materials: Evaluation and comparison after exposure to acidic drink 69
Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment 68
Case Report: Epstein-Barr virus negative lymphoepithelioma-like cholangiocarcinoma: a rare tumor that deserves further exploration. Report of a case with distinct genomic and clinical features 67
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) 66
The Role of Oncogenic Viruses in the Pathogenesis of Sporadic Breast Cancer: A Comprehensive Review of the Current Literature 64
COVID-19 and breast cancer: May the microbiome be the issue? 63
Reply to Y. Ergun et al 62
Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM) 46
Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma 43
Postvaccination immune-mediated hepatitis: what do we really know? 35
How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of View 11
Facing antimicrobial resistance in cancer care: what the AIOM survey tells us about oncologists' awareness 8
Totale 3.766
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.789
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202278 0 0 1 0 4 1 10 5 2 11 7 37
2022/2023285 22 29 4 26 21 13 0 10 114 2 40 4
2023/2024350 41 51 14 22 29 85 24 31 0 11 14 28
2024/2025834 26 40 45 9 11 60 54 50 186 48 109 196
2025/20262.066 133 113 218 229 251 97 349 125 201 155 130 65
2026/2027132 69 63 0 0 0 0 0 0 0 0 0 0
Totale 3.766